Gainers
- Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 13.3% to $0.37 during Friday's after-market session. The market value of their outstanding shares is at $4.3 million.
- Dyadic International (NASDAQ:DYAI) stock moved upwards by 12.12% to $1.48. The company's market cap stands at $42.6 million.
- Annovis Bio (NYSE:ANVS) shares increased by 8.33% to $11.3. The market value of their outstanding shares is at $119.5 million.
- Sagimet Biosciences (NASDAQ:SGMT) shares increased by 7.71% to $8.12. The market value of their outstanding shares is at $259.0 million.
- Motus GI Hldgs (NASDAQ:MOTS) shares rose 7.04% to $0.68. The company's market cap stands at $1.0 million.
- ProKidney (NASDAQ:PROK) stock rose 6.99% to $1.68. The company's market cap stands at $114.0 million.
Losers
- Universe Pharmaceuticals (NASDAQ:UPC) stock decreased by 21.6% to $1.93 during Friday's after-market session. The market value of their outstanding shares is at $7.0 million.
- Equillium (NASDAQ:EQ) stock declined by 12.62% to $2.41. The market value of their outstanding shares is at $84.7 million.
- Kazia Therapeutics (NASDAQ:KZIA) stock decreased by 9.34% to $0.32. The company's market cap stands at $8.4 million.
- Bright Green (NASDAQ:BGXX) stock decreased by 7.95% to $0.21. The market value of their outstanding shares is at $37.9 million.
- Lucy Scientific Discovery (NASDAQ:LSDI) stock decreased by 7.02% to $0.2. The company's market cap stands at $3.5 million. As per the news, the Q2 earnings report came out 2 days ago.
- NextCure (NASDAQ:NXTC) shares decreased by 6.85% to $1.36. The market value of their outstanding shares is at $37.9 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.